Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nello Martini

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Recenti Progressi in Medicina|July 4, 2018
[Does oncology change its paradigm? The challenge of agnostic approval of new therapies.]Nello Martini
Recenti Progressi in Medicina|May 18, 2021
[Long covid syndrome and real world evidence.]Nello Martini
Recenti Progressi in Medicina|November 18, 2020
[Citizens' engagement in healthcare.]Nello Martini
Recenti Progressi in Medicina|August 15, 2021
[The long path to adherence.]Nello Martini, Carlo Piccinni
Recenti Progressi in Medicina|June 27, 2013
[From the "note limitative" to the "registri AIFA"]Antonio Addis, Nello Martini
Recenti Progressi in Medicina|February 24, 2021
[New drugs and PDTA. Financing methodology for care pathways and overcoming of silos.]Nello Martini, Carlo Piccinni
Recenti Progressi in Medicina|April 11, 2019
[The new oncological mutational model. What changes in regulatory processes and in the reimbursement of cancer target therapies.]Antonella Pedrini, Nello Martini
Recenti Progressi in Medicina|December 20, 2021
[The tools for the governance of mutational oncology and agnostic drugs: from place in therapy to place in pathway.]Nello Martini, Carlo Piccinni
Recenti Progressi in Medicina|March 25, 2024
[The domino effect of drug distribution channels on the management of chronicity.]Carlo Piccinni, Nello Martini
Lancet (London, England)|July 5, 2003
Role of a research ethics committee in follow-up and publication of resultsNello Martini, Carlo Tomino, Alessandro Liberati
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Recenti Progressi in Medicina|July 4, 2018
[Does oncology change its paradigm? The challenge of agnostic approval of new therapies.]Nello Martini
Recenti Progressi in Medicina|May 18, 2021
[Long covid syndrome and real world evidence.]Nello Martini
Recenti Progressi in Medicina|November 18, 2020
[Citizens' engagement in healthcare.]Nello Martini
Recenti Progressi in Medicina|August 15, 2021
[The long path to adherence.]Nello Martini, Carlo Piccinni
Recenti Progressi in Medicina|June 27, 2013
[From the "note limitative" to the "registri AIFA"]Antonio Addis, Nello Martini
Recenti Progressi in Medicina|February 24, 2021
[New drugs and PDTA. Financing methodology for care pathways and overcoming of silos.]Nello Martini, Carlo Piccinni
Recenti Progressi in Medicina|April 11, 2019
[The new oncological mutational model. What changes in regulatory processes and in the reimbursement of cancer target therapies.]Antonella Pedrini, Nello Martini
Recenti Progressi in Medicina|December 20, 2021
[The tools for the governance of mutational oncology and agnostic drugs: from place in therapy to place in pathway.]Nello Martini, Carlo Piccinni
Recenti Progressi in Medicina|March 25, 2024
[The domino effect of drug distribution channels on the management of chronicity.]Carlo Piccinni, Nello Martini
Lancet (London, England)|July 5, 2003
Role of a research ethics committee in follow-up and publication of resultsNello Martini, Carlo Tomino, Alessandro Liberati
Pageof 10